JP2024537323A5 - - Google Patents

Info

Publication number
JP2024537323A5
JP2024537323A5 JP2024522070A JP2024522070A JP2024537323A5 JP 2024537323 A5 JP2024537323 A5 JP 2024537323A5 JP 2024522070 A JP2024522070 A JP 2024522070A JP 2024522070 A JP2024522070 A JP 2024522070A JP 2024537323 A5 JP2024537323 A5 JP 2024537323A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
antibody
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024522070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024537323A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/125725 external-priority patent/WO2023061505A1/en
Publication of JP2024537323A publication Critical patent/JP2024537323A/ja
Priority to JP2025006663A priority Critical patent/JP2025061426A/ja
Publication of JP2024537323A5 publication Critical patent/JP2024537323A5/ja
Pending legal-status Critical Current

Links

JP2024522070A 2021-10-15 2022-10-17 抗グリピカン3抗体 Pending JP2024537323A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025006663A JP2025061426A (ja) 2021-10-15 2025-01-17 抗グリピカン3抗体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2021/124182 2021-10-15
CN2021124182 2021-10-15
PCT/CN2022/125725 WO2023061505A1 (en) 2021-10-15 2022-10-17 Anti-glypican 3 antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025006663A Division JP2025061426A (ja) 2021-10-15 2025-01-17 抗グリピカン3抗体

Publications (2)

Publication Number Publication Date
JP2024537323A JP2024537323A (ja) 2024-10-10
JP2024537323A5 true JP2024537323A5 (cg-RX-API-DMAC7.html) 2025-11-10

Family

ID=85988149

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024522070A Pending JP2024537323A (ja) 2021-10-15 2022-10-17 抗グリピカン3抗体
JP2025006663A Pending JP2025061426A (ja) 2021-10-15 2025-01-17 抗グリピカン3抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025006663A Pending JP2025061426A (ja) 2021-10-15 2025-01-17 抗グリピカン3抗体

Country Status (5)

Country Link
US (2) US20240409663A1 (cg-RX-API-DMAC7.html)
EP (2) EP4527465A3 (cg-RX-API-DMAC7.html)
JP (2) JP2024537323A (cg-RX-API-DMAC7.html)
CN (3) CN118488970A (cg-RX-API-DMAC7.html)
WO (1) WO2023061505A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024061305A1 (zh) * 2022-09-22 2024-03-28 上海美雅珂生物技术有限责任公司 Gpc3抗体药物偶联物及其应用
CN119894935B (zh) * 2022-09-30 2026-06-19 信立泰(成都)生物技术有限公司 抗gpc3单克隆抗体/双特异性抗体或其抗原结合片段及其用途
WO2025045242A1 (zh) * 2023-09-01 2025-03-06 信立泰(成都)生物技术有限公司 一种靶向gpc3的双特异性抗体或抗原结合片段及其用途
EP4775226A1 (en) * 2023-09-05 2026-07-15 Lepu Biopharma Co., Ltd. Antibody drug conjugate targeting gpc3 and use thereof
KR20250116580A (ko) * 2024-01-24 2025-08-01 국립암센터 Gpc3에 특이적으로 결합하는 신규 항체를 이용한 키메라 항원 수용체 t 세포
WO2026016998A1 (zh) * 2024-07-15 2026-01-22 北京剂泰医药科技有限公司 编码针对GPC3和CD3双特异性抗体的mRNA分子

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6130364A (en) 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US6420140B1 (en) 1996-10-11 2002-07-16 Abgenix, Inc. Production of multimeric protein by cell fusion method
EP1411118B1 (en) * 2001-06-22 2008-09-03 Chugai Seiyaku Kabushiki Kaisha Cell proliferation inhibitors containing anti-glypican-3 antibody
WO2004022597A1 (ja) * 2002-09-04 2004-03-18 Chugai Seiyaku Kabushiki Kaisha Gpc3の血中可溶化n端ペプチドに対する抗体
AU2005256113B2 (en) * 2004-07-09 2011-02-10 Chugai Seiyaku Kabushiki Kaisha Anti-glypican 3 antibody
AU2008275985B2 (en) * 2007-07-17 2013-09-19 E. R. Squibb & Sons, L.L.C. Monoclonal antibodies against Glypican-3
CN101633693A (zh) * 2009-08-24 2010-01-27 中国人民解放军第二军医大学 一种抗gpc3的单克隆抗体
JP2017522861A (ja) * 2014-05-22 2017-08-17 ジェネンテック, インコーポレイテッド 抗gpc3抗体及びイムノコンジュゲート
US9926377B2 (en) * 2014-05-22 2018-03-27 Genentech, Inc. Anti-GPC3 antibodies and immunoconjugates
CN105037540A (zh) * 2015-05-13 2015-11-11 北京比洋生物技术有限公司 抗磷脂酰肌醇蛋白聚糖3全人源抗体
AU2016304060B2 (en) * 2015-08-03 2022-09-29 Crage Medical Co., Limited Antibody against glypican-3 and application thereof
CN109153719B (zh) * 2016-03-15 2022-12-30 中外制药株式会社 使用pd-1轴结合拮抗剂和抗gpc3抗体治疗癌症的方法
EP3615574B1 (en) * 2017-04-26 2026-06-24 Eureka Therapeutics, Inc. Constructs specifically recognizing glypican 3 and uses thereof
CN109988240B (zh) * 2017-12-29 2022-06-28 安源医药科技(上海)有限公司 抗gpc-3抗体及其用途
CN109021108B (zh) * 2018-08-27 2019-06-25 南京医科大学 抗gpc3全人源化抗体、其嵌合抗原受体细胞及应用
CN114340671A (zh) * 2019-08-01 2022-04-12 R.P.谢勒技术有限责任公司 对gpc3特异性的抗体及其使用方法
JP2025006663A (ja) * 2023-06-29 2025-01-17 積水化学工業株式会社 情報処理システム、情報処理方法及びプログラム

Similar Documents

Publication Publication Date Title
JP2023511774A5 (cg-RX-API-DMAC7.html)
JP2024150445A5 (cg-RX-API-DMAC7.html)
JP2023549537A5 (cg-RX-API-DMAC7.html)
JP2025513593A5 (cg-RX-API-DMAC7.html)
JP2022513420A5 (cg-RX-API-DMAC7.html)
RU2019116624A (ru) Новые анти_cd137 антитела и их применение
JP2022553922A5 (cg-RX-API-DMAC7.html)
RU2020103344A (ru) Конъюгаты антител с лекарственными средствами, характеризующиеся высокой in vivo переносимостью
JP2011501656A5 (cg-RX-API-DMAC7.html)
RU2017145150A (ru) Антитело против pdl-1, его фармацевтическая композиция и применение
US20250034273A1 (en) Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof
RU2020113027A (ru) Axl-специфичные антитела и их применения
CA2487060A1 (en) Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
JP2024001073A5 (cg-RX-API-DMAC7.html)
JP2021512107A5 (cg-RX-API-DMAC7.html)
JP2025069432A5 (cg-RX-API-DMAC7.html)
JP2022545741A5 (cg-RX-API-DMAC7.html)
JP2020534012A5 (cg-RX-API-DMAC7.html)
JP2018528759A5 (cg-RX-API-DMAC7.html)
JP2023544143A5 (cg-RX-API-DMAC7.html)
JP2024540148A5 (cg-RX-API-DMAC7.html)
JP2022512646A5 (cg-RX-API-DMAC7.html)
CN117279950B (zh) 一种靶向il-18bp的抗体及其应用
JP2025506248A5 (cg-RX-API-DMAC7.html)
CN120943966A (zh) TriAx抗体的组合物及其制备和使用方法